Showing 1 - 3 results of 3 for search 'Margaux Seite' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Margaux Seite
Showing 1 - 3 results of 3 for search 'Margaux Seite', query time: 0.02s Refine Results
  1. 1
    1369 CIS-demasking cytokine linker technology allows selective cytokine delivery to activated immune cells while sparing others and peripheral toxicity

    1369 CIS-demasking cytokine linker technology allows selective cytokine delivery to activated immune cells while sparing others and peripheral toxicity by Caroline Mary, Géraldine Teppaz, Virginie Thépénier, Nicolas Poirier, Aurore morello, Margaux Seite, Justine Durand, Cecile Batty, Julien Taurelle, Amandine Georges

    Published 2023-11-01
    Article
  2. 2
    1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy

    1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy... by Caroline Mary, Géraldine Teppaz, Ariane Desselle, Virginie Thépénier, Emmanuelle Wilhelm, Nicolas Poirier, Aurore morello, Margaux Seite, Justine Durand, Isabelle Girault, Cecile Batty, Marine Malloci

    Published 2023-11-01
    Article
  3. 3
    852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo

    852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo by Caroline Mary, Géraldine Teppaz, Ariane Desselle, Virginie Thépénier, Nicolas Poirier, Aurore morello, Margaux Seite, Justine Durand, Cecile Batty, Belarif Lyssia, Julien Taurelle, Berangere Vasseur, Thomas Vandewalle, Laurie Cordonnier

    Published 2023-11-01
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs